04.10.2022 - CELEBRATION, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) - KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a biotechnology company focused on the discovery, development and commercialization of novel treatments for rare diseases, announced . Seite 1